DrugPatentWatch Database Preview
Drugs in Development Information for Isoquinoline
Development status for investigational drug Isoquinoline: Patents, clinical trial progress, indications
Isoquinoline is an investigational drug.
There have been 10 clinical trials for Isoquinoline.
The most recent clinical trial was a Phase 1 trial, which was initiated on July 1st 2018.
The most common disease conditions in clinical trials are Taeniasis, Neurocysticercosis, and Cysticercosis. The leading clinical trial sponsors are National Institute of Mental Health (NIMH), University of Washington, and Kenya Medical Research Institute.
There are eight hundred and ninety-one US patents protecting this investigational drug and eleven international patents.
Summary for Isoquinoline
| US Patents | 891 |
| International Patents | 11,009 |
| US Patent Applications | 8,634 |
| WIPO Patent Applications | 0 |
| Japanese Patent Applications | 84 |
| Clinical Trial Progress | Phase 1 (2018-07-01) |
| Vendors | 83 |
Recent Clinical Trials for Isoquinoline
| Title | Sponsor | Phase |
|---|---|---|
| Comparation of Berberine and Metformin for the Treatment for MS in Schizophrenia Patients | Tianjin Anding Hospital | Phase 4 |
| Assessing Goldenseal-drug Interactions Using a Probe Drug Cocktail Approach | National Center for Complementary and Integrative Health (NCCIH) | Early Phase 1 |
| Assessing Goldenseal-drug Interactions Using a Probe Drug Cocktail Approach | Washington State University | Early Phase 1 |
Clinical Trial Summary for Isoquinoline
Top disease conditions for Isoquinoline
Top clinical trial sponsors for Isoquinoline
US Patents for Isoquinoline
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Isoquinoline | Start Trial | Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses | Bristol-Myers Squibb Company (Princeton, NJ) | Start Trial |
| Isoquinoline | Start Trial | Furo- and thieno-pyridine carboxamide compounds useful as pim kinase inhibitors | Incyte Corporation (Wilmington, DE) | Start Trial |
| Isoquinoline | Start Trial | Crystalline dimethyl 3-(benzyloxy)-1-(2,2-dimethoxyethyl)-4-oxo-1,4-dihydropyridine-2,5-dicarb- oxylate | Shionogi & Co., Ltd (JP) | Start Trial |
| Isoquinoline | Start Trial | Organic electroluminescent materials and devices | Universal Display Corporation (Ewing, NJ) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Isoquinoline
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Isoquinoline | Argentina | 094452 | 2032-11-08 | Start Trial |
| Isoquinoline | Australia | 2013341186 | 2032-11-08 | Start Trial |
| Isoquinoline | Australia | 2017201076 | 2032-11-08 | Start Trial |
| Isoquinoline | Australia | 2018267545 | 2032-11-08 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
